Chronic Thromboembolic Pulmonary Hypertension Drugs Under Development 2018 Report Covers Key-players(Actelion, Bayer Healthcare Pharmaceuticals, SciPharm SàRL)
Chronic Thromboembolic Pulmonary Hypertension Pipeline insight report starts with an overview of Chronic Thromboembolic Pulmonary Hypertension and Pipeline Products for Chronic Thromboembolic Pulmonary Hypertension. Further report explains comparative pipeline therapeutics assessment of Chronic Thromboembolic Pulmonary Hypertension by development stage, by therapy type, by route of administration and by molecule type.
View full press release